ESC 365 - Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo

HFA Premium Access

Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity in vitro and in vivo

Session: Poster Session 1 - Basic Science: Co-morbidities

Topic: Cancer/Cardiotoxicity

Speaker: Professor W. Kim (Seoul, KR)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Weon Kim

Kyung Hee Medical Center, Seoul (Korea (Republic of))

0 follower

4 more presentations in this session

Enalapril, eplerenone or their combination: finding the best paradigm to protect against Doxorubicin-Induced Cardiotoxicity

Speaker: Professor R. Hullin (Lausanne, CH)

Ranolazine protects from trastuzumab cardiomyopathy

Speaker: Doctor N. Maurea (Naples, IT)

Sildenafil treatment in a rat model of cancer cachexia

Speaker: Doctor S. Nucera (Catanzaro, IT)

TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

Speaker: Assistant Professor M. Trofenciuc (Arad, RO)

Access the full session

Poster Session 1 - Basic Science: Co-morbidities

Speakers: Professor W. Kim, Professor R. Hullin, Doctor N. Maurea, Doctor S. Nucera, Assistant Professor M. Trofenciuc

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources